I am guesstimating profit potentiality of $5.25 - $5.35
as CRIS is getting good results and reaping the monetary benefits recently. This appears to be a buy/hold opportunity.
RBY is another one, though my RVM is also a buy/hold today.
Well its sales seem to be improving, PE ratio is still quite high, but what do you expect from new drug sales. European approval would give those sales numbers a great big boost though. I suspecy CHMP will rule in February, its overdue at this point.